Jeph Herrin

Yale University

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Biostatistics

10%

Epidemiology

10%

Insulin Resistance

30%

Cardiometabolic Health

20%

Diabetes Prevention

20%

Retinal Disease

20%

Cardiovascular Risk

10%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Evaluating Blood Pressure Response Patterns to Exercise Stress Testing

Article Link

Year:

2025

Impact of Interventions to Improve Human Papillomavirus Vaccine Uptake on Other Vaccines Due: A Secondary Analysis of a Randomized Trial

Article Link

Year:

2025

Comparative effectiveness of GLP-1 receptor agonists on cardiovascular outcomes among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target trial

Article Link

Year:

2025

Trends in Osteoporosis Drug Therapy Receipt Among Commercial and Medicare Advantage Enrollees in the United States, 2011-2022

Article Link

Year:

2025

Heterogeneity of Cardiovascular Effects of Second‐Line Glucose‐Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk

Article Link

Year:

2025

Risk of Sight-Threatening Diabetic Retinopathy with Glucagon-Like Peptide-1 Receptor Agonist Use in Routine Clinical Practice

Article Link

Year:

2025

Kidney Outcomes with Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes and Moderate Cardiovascular Risk

Article Link

Year:

2025

Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy

Article Link

Year:

2024

Sex-specific associations between habitual snoring and cancer prevalence: insights from a US Cohort Study

Article Link

Year:

2024

Prevalence, Severity, and Co-Occurrence of SPPADE Symptoms in 31,866 Patients With Cancer

Article Link

Year:

2023

Collaborators7

Edward Miller

Associated Professor of Medicine (Cardiology) & Radiology and Biomedical Imaging

Yale University

UNITED STATES

Guillermo Umpierrez

Professor of Medicine

Emory University School of Medicine

UNITED STATES

Rozalina McCoy

Associate Professor of Medicine

University of Maryland School of Medicine

UNITED STATES

Kathy MacLaughlin

Associate Professor of Family Medicine

Mayo Clinic Rochester

UNITED STATES

Joseph Ross

Professor

Yale University School of Medicine

UNITED STATES

Yuan Lu

Assistant Professor

Yale University

UNITED STATES

Joan Griffin

Professor

Mayo Clinic

UNITED STATES

How do I reach out?

Meet Kite AI